Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

Share Price Information for Kanabo Grp Plc (KNB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.70
Ask: 2.00
Change: 0.00 (0.00%)
Spread: 0.30 (17.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.85
KNB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kanabo to present at Mello: 29 November 2021

26 Nov 2021 11:57

RNS Number : 7586T
Kanabo Group PLC
26 November 2021
 

Kanabo Group Plc 

 

("Kanabo" or "the Company") 

 

Investor presentation - Mello Monday

 

Kanabo Group Plc (LSE:KNB), a leading processor and distributor of medical cannabis and CBD wellness products across Europe, will be presenting at Mello Monday on Monday 29th November 2021. Avihu Tamir, CEO, will be presenting at 8.00pm and taking questions from registered participants.

Kanabo is committed to ensuring best-in-class investor communications across all classes of investor so that its strategy, business model and financial performance are clearly available and understood.

If you would like to attend, register using the link below, using code SHVIP for 75% off tickets:

MelloMonday 29th November - Mello Events

 

For further information, please contact: 

Kanabo Group Plc

 

Avihu Tamir, CEO

Via Vox Markets 

 

Peterhouse Capital Ltd 

 

Eran Zuckwer / Guy Miller (Financial Adviser)

Tel: +44 (0)20 7469 0930

Lucy Williams / Charles Goodfellow (Corporate Broker)

Tel: +44 (0)20 7469 0930

 

Vox Markets (Investor Relations)

 

Kat Perez

KanaboGroup@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is an R&D company currently selling a range of THC-Free Retail CBD Products in the Primary Markets and is in the process of developing further Medical Cannabis Products. The company's core strategy is to increase revenues from the sale of its Retail CBD Products in the wellness sector and to grow the Kanabo brand through its marketing initiatives. 

 

Follow Kanabo and learn more here; https://www.voxmarkets.co.uk/listings/LON/KNB/

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABFBBTMTATBFB
Date   Source Headline
4th Nov 20217:00 amRNSUpdate on Materia Acquisition
29th Oct 20217:00 amRNSTotal Voting Rights
22nd Oct 20217:00 amRNSHalf-year Report
7th Oct 20217:00 amRNSNew Partnership Agreement
30th Sep 20217:00 amRNSTotal Voting Rights
22nd Sep 20217:00 amRNSCBD Line Launched in the UK on HandpickedCBD.com
14th Sep 20217:05 amRNSMateria Receives Licence for Malta Facility
31st Aug 20211:51 pmRNSTotal Voting Rights
17th Aug 202111:05 amRNSSecond Price Monitoring Extn
17th Aug 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSUpdate: New contract signed by Materia
2nd Aug 20217:01 amRNSUpdate re: Investment & MoU with Hellenic Dynamics
30th Jul 202112:49 pmRNSTotal Voting Rights
26th Jul 202111:05 amRNSSecond Price Monitoring Extn
26th Jul 202111:00 amRNSPrice Monitoring Extension
26th Jul 20217:00 amRNSProposed Acquisition
22nd Jul 20213:32 pmRNSBlock Listing Application
14th Jul 20217:00 amRNSKanabo’s First Medical Cannabis Product in UK
8th Jul 20211:00 pmRNSIssue of Equity
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20217:00 amRNSAppointment of Director & Grant of Options
28th Jun 20213:41 pmRNSResult of AGM
25th Jun 20217:00 amRNSInitial Commercial Scale Production
24th Jun 20213:58 pmRNSIssue of Equity
17th Jun 20212:59 pmRNSIssue of Equity
4th Jun 20217:00 amRNSSupport for New Campaign
3rd Jun 202112:00 pmRNSNotice of AGM
2nd Jun 20219:26 amRNSAnnual Financial Report
26th May 20213:36 pmRNSAdmission of Placing Shares
24th May 20217:00 amRNSPlacing, Investment & MoU with Hellenic Dynamics
20th May 20217:00 amRNSNew EU GMP CBD Manufacturing Agreement
14th May 20212:00 pmRNSIssue of Equity
11th May 20211:09 pmRNSIssue of Equity
6th May 20212:00 pmRNSIssue of Equity
26th Apr 20213:03 pmRNSIssue of Equity
21st Apr 20212:57 pmRNSIssue of Equity
14th Apr 20214:01 pmRNSIssue of Equity
8th Apr 20213:15 pmRNSQ1 Summary
31st Mar 20214:51 pmRNSTotal Voting Rights
30th Mar 20213:26 pmRNSIssue of Equity
26th Mar 20217:00 amRNSPDMR Notification
23rd Mar 20218:47 amRNSPublication of Research Note
16th Mar 20212:42 pmRNSIssue of Equity
9th Mar 202111:06 amRNSSecond Price Monitoring Extn
9th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSMedicinal Cannabis Production Agreement
8th Mar 20213:42 pmRNSChange of Registered Address
23rd Feb 20217:00 amRNSUK Medicinal Cannabis Distribution Agreement
22nd Feb 20219:05 amRNSSecond Price Monitoring Extn
22nd Feb 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.